References
- Jpn. J. Cancer Res. v.90 In vitro antitumor activity of TAS-103, a novel quinoline derivative that targets topoisomerasesⅠandⅡ Aoyagi,Y.;Kobunai,T.;Utsugi,T.;Oh-hara,T.;Yamada,Y.
- J. Am. Chem. Soc. v.68 Substituted Lepidines Kaslow,C.E.;Sommer,N.B.
- Arch. Pharm. Res. v.23 Synthesis and in Vitro Cytotoxicity of 2-Alkylaminosubstituted Quinoline Derivatives Lee,H.;Lee,J.;Hong,S.S.;Yang,S.I.;Jung,S.H.;Jahng,Y.;Cho,J.
- Cancer Chemother. Pharmacol. v.45 Mechnism of action of the dual topoisomerase-Ⅰand-Ⅱ inhibitor TAS-103 and activity against (multi)drug resistant cells Minderman,H.;Wrzosek,C.;Cao,S.S.;Utsugi,T.;Kobunai,T.;Yamada,Y.;Rustum,Y.M.
- J. Org. Chem. v.51 Cycloaddition Routes to Azaanthraquinone Derivatives.1.Use of Azadienophiles Potts,K.T.;Bhattachaarjee,D.;Walsh,E.B.
- J. Natl. Cancer Inst. v.82 New colorimetric cytotoxicity assay for anticancer-drug screening Skehan,P.;Storeng,R.;Scudiero,D.;Monks,A.;McMahon,J.;Vistica,D.;Warren,J.T.;Bokesch,H.;Kenny,S.;Boyd,M.R.